pharma · Advanced Cancer · Advanced Solid Tumors · TCRT
Alaunos Therapeutics
Alaunos Therapeutics is a pharma organization headquartered in Houston, USA. It trades on NYSE under ticker TCRT. Primary therapeutic focus areas include Advanced Cancer, Advanced Solid Tumors, Solid Tumors, Melanoma, Me
8030 El Rio St, Houston, Texas 77054, US HQ
10 Employees
Public company Type
TCRT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 8030 El Rio St, Houston, Texas 77054, US
- Employees
- 10
- Programs
- 34
- Drugs
- 12
- Patents
- 0
doxorubicin in combination with palifosfamide-tris
Phase 3 · small molecule · Soft Tissue Sarcoma
doxorubicin in combination with palifosfamide-tris for Soft Tissue Sarcoma is a Phase 3 program (small_molecule) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code IPM3001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Alaunos Therapeutics
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Soft Tissue Sarcoma
- Status
- completed
- Trials
- 1